SRPT logo

Sarepta Therapeutics (SRPT) Retained earnings

annual retained earnings:

-$4.21B+$235.24M(+5.29%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual retained earnings is -$4.21 billion, with the most recent change of +$235.24 million (+5.29%) on December 31, 2024.
  • During the last 3 years, SRPT annual retained earnings has fallen by -$1.00 billion (-31.32%).
  • SRPT annual retained earnings is now -33859.47% below its all-time high of -$12.40 million, reached on December 31, 1996.

Performance

SRPT Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly retained earnings:

-$4.66B-$447.51M(-10.63%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly retained earnings is -$4.66 billion, with the most recent change of -$447.51 million (-10.63%) on March 1, 2025.
  • Over the past year, SRPT quarterly retained earnings has dropped by -$248.39 million (-5.63%).
  • SRPT quarterly retained earnings is now -35734.48% below its all-time high of -$13.00 million, reached on March 31, 1997.

Performance

SRPT quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

SRPT Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.3%-5.6%
3 y3 years-31.3%-40.7%
5 y5 years-83.6%-101.5%

SRPT Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-31.3%+5.3%-40.7%at low
5 y5-year-83.6%+5.3%-101.5%at low
alltimeall time<-9999.0%+5.3%<-9999.0%at low

SRPT Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$4.66B(+10.6%)
Dec 2024
-$4.21B(-5.3%)
-$4.21B(-3.6%)
Sep 2024
-
-$4.37B(-0.8%)
Jun 2024
-
-$4.40B(-0.1%)
Mar 2024
-
-$4.41B(-0.8%)
Dec 2023
-$4.45B(+13.7%)
-$4.45B(-1.0%)
Sep 2023
-
-$4.49B(+0.9%)
Jun 2023
-
-$4.45B(+0.5%)
Mar 2023
-
-$4.43B(+13.2%)
Dec 2022
-$3.91B(+21.9%)
-$3.91B(+2.9%)
Sep 2022
-
-$3.80B(+7.3%)
Jun 2022
-
-$3.54B(+7.0%)
Mar 2022
-
-$3.31B(+3.3%)
Dec 2021
-$3.21B(+12.6%)
-$3.21B(+4.0%)
Sep 2021
-
-$3.08B(+1.6%)
Jun 2021
-
-$3.04B(+2.8%)
Mar 2021
-
-$2.96B(+3.8%)
Dec 2020
-$2.85B(+24.2%)
-$2.85B(+7.1%)
Sep 2020
-
-$2.66B(+8.0%)
Jun 2020
-
-$2.46B(+6.5%)
Mar 2020
-
-$2.31B(+0.8%)
Dec 2019
-$2.29B(+45.3%)
-$2.29B(+11.5%)
Sep 2019
-
-$2.06B(+6.5%)
Jun 2019
-
-$1.93B(+16.7%)
Mar 2019
-
-$1.66B(+4.9%)
Dec 2018
-$1.58B(+29.7%)
-$1.58B(+9.8%)
Sep 2018
-
-$1.44B(+5.6%)
Jun 2018
-
-$1.36B(+8.7%)
Mar 2018
-
-$1.25B(+2.9%)
Dec 2017
-$1.22B(+4.3%)
-$1.22B(+2.0%)
Sep 2017
-
-$1.19B(+4.2%)
Jun 2017
-
-$1.15B(+5.8%)
Mar 2017
-
-$1.08B(-7.2%)
Dec 2016
-$1.17B(+29.7%)
-$1.17B(+8.2%)
Sep 2016
-
-$1.08B(+5.6%)
Jun 2016
-
-$1.02B(+6.5%)
Mar 2016
-
-$958.83M(+6.6%)
Dec 2015
-$899.05M(+32.4%)
-$899.05M(+7.8%)
Sep 2015
-
-$834.37M(+6.6%)
Jun 2015
-
-$782.43M(+5.7%)
Mar 2015
-
-$740.58M(+9.1%)
Dec 2014
-$679.02M(+25.0%)
-$679.02M(+7.0%)
Sep 2014
-
-$634.61M(+4.8%)
Jun 2014
-
-$605.38M(+5.9%)
Mar 2014
-
-$571.51M(+5.2%)
Dec 2013
-$543.24M(+26.0%)
-$543.24M(+1.7%)
Sep 2013
-
-$534.42M(+8.5%)
Jun 2013
-
-$492.39M(+4.0%)
Mar 2013
-
-$473.33M(+9.8%)
Dec 2012
-$431.25M(+39.1%)
-$431.25M(+16.8%)
Sep 2012
-
-$369.18M(+15.5%)
Jun 2012
-
-$319.63M(-2.5%)
Mar 2012
-
-$327.67M(+5.7%)
Dec 2011
-$309.96M(+0.8%)
-$309.96M(+0.5%)
Sep 2011
-
-$308.55M(+1.3%)
Jun 2011
-
-$304.53M(-0.4%)
Mar 2011
-
-$305.81M(-0.6%)
DateAnnualQuarterly
Dec 2010
-$307.65M(+11.7%)
-$307.65M(+2.5%)
Sep 2010
-
-$300.00M(+2.5%)
Jun 2010
-
-$292.71M(+6.0%)
Mar 2010
-
-$276.05M(+0.2%)
Dec 2009
-$275.47M(+10.1%)
-$275.47M(-1.3%)
Sep 2009
-
-$278.99M(+3.0%)
Jun 2009
-
-$270.90M(+7.8%)
Mar 2009
-
-$251.24M(+0.4%)
Dec 2008
-$250.31M(+10.6%)
-$250.31M(+0.5%)
Sep 2008
-
-$249.17M(+2.5%)
Jun 2008
-
-$243.12M(+0.7%)
Mar 2008
-
-$241.37M(+6.6%)
Dec 2007
-$226.36M(+11.1%)
-$226.36M(+1.9%)
Sep 2007
-
-$222.23M(+0.1%)
Jun 2007
-
-$221.98M(+4.0%)
Mar 2007
-
-$213.44M(+4.8%)
Dec 2006
-$203.72M(+18.0%)
-$203.72M(+4.3%)
Sep 2006
-
-$195.39M(+3.6%)
Jun 2006
-
-$188.61M(+3.8%)
Mar 2006
-
-$181.71M(+5.2%)
Dec 2005
-$172.65M(+10.7%)
-$172.65M(+2.7%)
Sep 2005
-
-$168.10M(+1.0%)
Jun 2005
-
-$166.40M(+3.1%)
Mar 2005
-
-$161.47M(+3.5%)
Dec 2004
-$155.97M(+18.9%)
-$155.97M(+3.3%)
Sep 2004
-
-$150.98M(+3.5%)
Jun 2004
-
-$145.88M(+5.2%)
Mar 2004
-
-$138.73M(+5.7%)
Dec 2003
-$131.19M(+12.5%)
-$131.19M(+2.4%)
Sep 2003
-
-$128.10M(+3.7%)
Jun 2003
-
-$123.49M(+2.9%)
Mar 2003
-
-$120.00M(+2.9%)
Dec 2002
-$116.58M(+33.7%)
-$116.58M(+3.5%)
Sep 2002
-
-$112.58M(+6.7%)
Jun 2002
-
-$105.53M(+11.0%)
Mar 2002
-
-$95.04M(+9.0%)
Dec 2001
-$87.22M(+44.7%)
-$87.22M(+5.6%)
Sep 2001
-
-$82.61M(+23.3%)
Jun 2001
-
-$67.02M(+5.6%)
Mar 2001
-
-$63.47M(+5.3%)
Dec 2000
-$60.29M(+18.0%)
-$60.29M(+5.2%)
Sep 2000
-
-$57.29M(+4.1%)
Jun 2000
-
-$55.03M(+5.4%)
Mar 2000
-
-$52.19M(+2.1%)
Dec 1999
-$51.10M(+19.4%)
-$51.10M(+4.9%)
Sep 1999
-
-$48.70M(+4.7%)
Jun 1999
-
-$46.50M(+4.5%)
Mar 1999
-
-$44.50M(+4.0%)
Dec 1998
-$42.80M(+167.5%)
-$42.80M(+5.9%)
Sep 1998
-
-$40.40M(+111.5%)
Jun 1998
-
-$19.10M(+9.1%)
Mar 1998
-
-$17.50M(+9.4%)
Dec 1997
-$16.00M(+29.0%)
-$16.00M(+5.3%)
Sep 1997
-
-$15.20M(+6.3%)
Jun 1997
-
-$14.30M(+10.0%)
Mar 1997
-
-$13.00M
Dec 1996
-$12.40M
-

FAQ

  • What is Sarepta Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual retained earnings year-on-year change?
  • What is Sarepta Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly retained earnings year-on-year change?

What is Sarepta Therapeutics annual retained earnings?

The current annual retained earnings of SRPT is -$4.21B

What is the all time high annual retained earnings for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual retained earnings is -$12.40M

What is Sarepta Therapeutics annual retained earnings year-on-year change?

Over the past year, SRPT annual retained earnings has changed by +$235.24M (+5.29%)

What is Sarepta Therapeutics quarterly retained earnings?

The current quarterly retained earnings of SRPT is -$4.66B

What is the all time high quarterly retained earnings for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly retained earnings is -$13.00M

What is Sarepta Therapeutics quarterly retained earnings year-on-year change?

Over the past year, SRPT quarterly retained earnings has changed by -$248.39M (-5.63%)
On this page